172 related articles for article (PubMed ID: 27318322)
1. A new, simple and robust radioligand binding method used to determine kinetic off-rate constants for unlabeled ligands. Application at α2A- and α2C-adrenoceptors.
Uhlén S; Schiöth HB; Jahnsen JA
Eur J Pharmacol; 2016 Oct; 788():113-121. PubMed ID: 27318322
[TBL] [Abstract][Full Text] [Related]
2. The C-terminal half of the α2C-adrenoceptor determines the receptor's membrane expression level and drug selectivity.
Jahnsen JA; Uhlén S
Naunyn Schmiedebergs Arch Pharmacol; 2013 Dec; 386(12):1031-40. PubMed ID: 23868076
[TBL] [Abstract][Full Text] [Related]
3. [3H]RS79948-197 binding to human, rat, guinea pig and pig alpha2A-, alpha2B- and alpha2C-adrenoceptors. Comparison with MK912, RX821002, rauwolscine and yohimbine.
Uhlén S; Dambrova M; Näsman J; Schiöth HB; Gu Y; Wikberg-Matsson A; Wikberg JE
Eur J Pharmacol; 1998 Feb; 343(1):93-101. PubMed ID: 9551719
[TBL] [Abstract][Full Text] [Related]
4. α
Sánchez-Soto M; Casadó-Anguera V; Yano H; Bender BJ; Cai NS; Moreno E; Canela EI; Cortés A; Meiler J; Casadó V; Ferré S
Mol Neurobiol; 2018 Nov; 55(11):8438-8454. PubMed ID: 29552726
[TBL] [Abstract][Full Text] [Related]
5. Quantification of alpha2A and alpha2C adrenoceptors in the rat striatum and in different regions of the spinal cord.
Uhlén S; Lindblom J; Tiger G; Wikberg JE
Acta Physiol Scand; 1997 Aug; 160(4):407-12. PubMed ID: 9338523
[TBL] [Abstract][Full Text] [Related]
6. alpha2C adrenoceptors inhibit adenylyl cyclase in mouse striatum: potential activation by dopamine.
Zhang W; Klimek V; Farley JT; Zhu MY; Ordway GA
J Pharmacol Exp Ther; 1999 Jun; 289(3):1286-92. PubMed ID: 10336518
[TBL] [Abstract][Full Text] [Related]
7. Rabbit alpha2-adrenoceptors: both platelets and adipocytes have alpha2A-pharmacology.
Naselsky DP; Ashton D; Ruffolo RR; Hieble JP
J Pharmacol Exp Ther; 2001 Jul; 298(1):219-25. PubMed ID: 11408545
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanisms of ligand-receptor interactions in transmembrane domain V of the alpha2A-adrenoceptor.
Peltonen JM; Nyrönen T; Wurster S; Pihlavisto M; Hoffrén AM; Marjamäki A; Xhaard H; Kanerva L; Savola JM; Johnson MS; Scheinin M
Br J Pharmacol; 2003 Sep; 140(2):347-58. PubMed ID: 12970108
[TBL] [Abstract][Full Text] [Related]
9. Reduced expression of alpha2C-adrenoceptors in rat striatum following antisense oligodeoxynucleotide infusion.
Lu L; Ordway GA
Brain Res Mol Brain Res; 1997 Jul; 47(1-2):267-74. PubMed ID: 9221925
[TBL] [Abstract][Full Text] [Related]
10. Spiroxatrine derivatives towards 5-HT
Sorbi C; Tait A; Battisti UM; Brasili L
Pharmacol Rep; 2020 Apr; 72(2):427-434. PubMed ID: 32002826
[TBL] [Abstract][Full Text] [Related]
11. Identification of drugs subtype-selective for alpha 2A-, alpha 2B-, and alpha 2C-adrenoceptors in the pig cerebellum and kidney cortex.
Wikberg-Matsson A; Wikberg JE; Uhlén S
Eur J Pharmacol; 1995 Sep; 284(3):271-9. PubMed ID: 8666009
[TBL] [Abstract][Full Text] [Related]
12. Agonist efficacy at the alpha2A-adrenoceptor:G alpha15 fusion protein: an analysis based on Ca2+ responses.
Pauwels PJ; Finana F; Tardif S; Colpaert FC; Wurch T
Naunyn Schmiedebergs Arch Pharmacol; 2000 Jun; 361(6):672-9. PubMed ID: 10882043
[TBL] [Abstract][Full Text] [Related]
13. Yohimbine dimers exhibiting selectivity for the human alpha 2C-adrenoceptor subtype.
Lalchandani SG; Lei L; Zheng W; Suni MM; Moore BM; Liggett SB; Miller DD; Feller DR
J Pharmacol Exp Ther; 2002 Dec; 303(3):979-84. PubMed ID: 12438517
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterization and CNS effects of a novel highly selective alpha2C-adrenoceptor antagonist JP-1302.
Sallinen J; Höglund I; Engström M; Lehtimäki J; Virtanen R; Sirviö J; Wurster S; Savola JM; Haapalinna A
Br J Pharmacol; 2007 Feb; 150(4):391-402. PubMed ID: 17220913
[TBL] [Abstract][Full Text] [Related]
15. A simple method for calculating the dissociation constant of a receptor (or enzyme).unlabeled ligand complex from radioligand displacement measurements.
Martin RL; Renosto F; Segel IH
Arch Biochem Biophys; 1991 Jan; 284(1):26-9. PubMed ID: 1989501
[TBL] [Abstract][Full Text] [Related]
16. The novel alpha-2 adrenergic radioligand [3H]-MK912 is alpha-2C selective among human alpha-2A, alpha-2B and alpha-2C adrenoceptors.
Uhlén S; Porter AC; Neubig RR
J Pharmacol Exp Ther; 1994 Dec; 271(3):1558-65. PubMed ID: 7996470
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular effects of rilmenidine, moxonidine and clonidine in conscious wild-type and D79N alpha2A-adrenoceptor transgenic mice.
Zhu QM; Lesnick JD; Jasper JR; MacLennan SJ; Dillon MP; Eglen RM; Blue DR
Br J Pharmacol; 1999 Mar; 126(6):1522-30. PubMed ID: 10217548
[TBL] [Abstract][Full Text] [Related]
18. Buffers differentially alter the binding of [3H]rauwolscine and [3H]RX821002 to the alpha-2 adrenergic receptor subtypes.
Deupree JD; Hinton KA; Cerutis DR; Bylund DB
J Pharmacol Exp Ther; 1996 Sep; 278(3):1215-27. PubMed ID: 8819505
[TBL] [Abstract][Full Text] [Related]
19. A quantitative method of analyzing the interaction of slightly selective radioligands with multiple receptor subtypes.
McGonigle P; Neve KA; Molinoff PB
Mol Pharmacol; 1986 Oct; 30(4):329-37. PubMed ID: 2876374
[TBL] [Abstract][Full Text] [Related]
20. Centhaquin antinociception in mice is mediated by α2A- and α2B- but not α2C-adrenoceptors.
Bhalla S; Ali I; Andurkar SV; Gulati A
Eur J Pharmacol; 2013 Sep; 715(1-3):328-36. PubMed ID: 23712005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
